Jack Ferracane, Ph.D., is editor-and-chief of a newly announced research journal from the American Dental Association.

Legislators with ties to OHSU are instrumental in sending a ballot measure to Oregon voters next year to determine whether health care should be considered a right in the Oregon Constitution.

New research in mice led by Jacob Raber, Ph.D., finds chronic exposure to second-hand-smoke results in lower body weight and cognitive impairments that more profoundly affects males.

A story cites new results of clinical work led by Cary Harding, M.D., that revealed no serious safety problems among 11 patients undergoing gene therapy to treat an inherited liver disorder with an adeno-associated virus, or AAV.

Terri Hough, M.D., moderates a panel discussion of a clinical trial involving a cocktail of two monoclonal antibodies that appears to reduce hospitalization and death by 71% compared with a placebo.

Health authorities in Hood River and The Dalles are asking people to test a new COVID-19 diagnostic tool.

Twenty-five years ago, Camp Sherman resident Gary Albertson received a transplant at OHSU thanks to his sister’s kidney donation.

An experimental gene therapy to treat the rare liver disorder ornithine transcarbamylase deficiency hasn’t resulted in any serious safety problems, which “absolutely” marks a milestone, says study co-investigator Cary Harding, M.D.

Gov. Brown visits the All4Oregon mass vaccination site May 18 to commemorate the 500,000th vaccination: “It’s truly extraordinary.”

Yifan Jian, Ph.D., is awarded an NIH grant to determine whether the eye imaging technologies optical coherence tomography and OCT angiography might lead to more accurate and objective diagnosis of retinopathy of prematurity.